secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001213900-24-043196
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Laboratories to effect 1-for-100 reverse stock split on May 17, 2024
-------------------------------------------------------------------------------

- Reverse stock split of common stock and warrants at 1-for-100 ratio, effective at market open on May 17, 2024.
- Post-split CUSIP for common stock is 42254E302; trading symbols HSCS and HSCSW unchanged.
- Warrant exercise price adjusted proportionally to $425.00 per share; fractional shares rounded up.
- Adjustments to outstanding warrants ensure equitable conversion for holders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000121390024043196/0001213900-24-043196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000121390024043196/ea0206149-8k_heart.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-043196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer